Call for Abstract
Scientific Program
2nd International Conference and Exhibition on In Silico Drug Designing & QSAR, will be organized around the theme “In Silico Drug Designing Strategies and Approaches ”
Drug Designing-2013 is comprised of 9 tracks and 47 sessions designed to offer comprehensive sessions that address current issues in Drug Designing-2013.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Target discovery
- Track 1-2Drug discovery
- Track 1-3Safety and drug metabolism
- Track 1-4Clinical trials
- Track 1-5Registration and pharmacovigilance
- Track 2-1Systems dynamics
- Track 2-2Computational approaches to dynamic systems
- Track 2-3Medical and microbial systems biology
- Track 2-4Metabolic engineering
- Track 2-5Genome design
- Track 2-6Next generation tools for systems biology
- Track 3-1Translation of animal models to the clinic
- Track 3-2Biomarkers in translational medicine
- Track 3-3Developing predictive preclinical models
- Track 3-4Translational modelling of efficacy & safety
- Track 4-1Pharmacophore modelling in drug design
- Track 4-2Introduction to population pharmacokinetics
- Track 4-3Multicompartment kinetics
- Track 4-4New tools & methods in PK/PD
- Track 4-5Pharmacokinetics and pharmacodynamics modelling
- Track 4-6Application of pharmacokinetics in clinical practice
- Track 5-1CADD in protein therapeutics
- Track 5-2Computational approaches to polypharmacology
- Track 5-3Structure-based drug design to identify novel oral & inhaled p38 inhibitors for copd
- Track 5-4Drug binding and subtype selectivity in g-protein-coupled receptors
- Track 6-1Molecular modelling and simulation
- Track 6-2Novel drugable targets: Identification and selection
- Track 6-3Fragment binding and selectivity
- Track 6-4Structure-based inhibitor design
- Track 6-5Ligand design and identification
- Track 6-6Target-ligand interaction (including proteins and nucleic acids)
- Track 6-7In silico and experimental screening technologies
- Track 7-1Docking approaches and tools involved
- Track 7-2Virtual screening techniques and docking
- Track 7-3Scoring methods
- Track 7-4Parameters influencing the docking results
- Track 8-1QSAR techniques applied to 5HT3 receptor antagonists
- Track 8-2QSAR in the real world
- Track 8-3New techniques in lead optimisation by Qsar
- Track 8-4Neural networks in qsar: Uses and abuses
- Track 8-5Problems and pitfalls in Qsar
- Track 9-1ADME and metabolomics
- Track 9-2ADME optimisation for drug design/discovery
- Track 9-3Genotoxicity and toxicokinetic modeling
- Track 9-4New therapeutic targets in drug design/discovery
- Track 9-5Pharmacogenomics and drug safety
- Track 9-6Regulatory Issues in ADME